Explore 3 Stock Ideas & Industry Insights Download Free Report

News

State Street Reports 5.4% Stake in Fidelity National Information Services

State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of approximately 5.4% of Fidelity National Information Services Inc's common stock as of September 30, 2026.

Aditi Sarkar | 10 November 2026

Pyxus Launches Exchange Offer for 8.50% Notes Due 2027

Pyxus International, Inc. filed a Form 8-K on November 10, 2026, announcing that it and its wholly-owned subsidiary, Pyxus Holdings, Inc., have commenced a private exchange offer for all outstanding 8.50% Senior Secured Notes due 2027.

Vinay Lochav | 10 November 2026

State Street Reports 4.9% Stake in Fox Corp Common Stock

State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 10,723,159 shares of Fox Corp common stock as of September 30, 2026.

Vinay Lochav | 10 November 2026

State Street Reports 4.2% Stake in FMC Corp as of Sept. 30

State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing a beneficial ownership position in FMC Corp common stock as of the September 30, 2026 event date.

Anjali Anand | 10 November 2026

State Street Reports 7.3% Fox Corp Common Stock Stake

State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 14,739,582 shares of Fox Corp common stock as of September 30, 2026.

Vinay Lochav | 10 November 2026

State Street Discloses 4.7% Stake in Forum Energy Technologies

State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing beneficial ownership of 528,189 shares of Forum Energy Technologies Inc common stock, representing 4.7% of the class, as of September 30, 2026.

Manish Choudhary | 10 November 2026

Autolus Therapeutics Files Q3 2026 Earnings 8-K

Autolus Therapeutics plc filed a Current Report on Form 8-K on November 10, 2026, announcing its financial results for the quarter ended September 30, 2026, and furnishing an updated corporate presentation used in connection with a same-day conference call.

Manish Choudhary | 10 November 2026

Passage Bio Q3 2026: Cash at $20,160 Thousand, Leases Wound Down

Passage Bio, Inc. filed its quarterly report on Form 10-Q with the SEC on November 10, 2026, covering the period ended September 30, 2026, and reporting significant changes to its balance sheet compared to December 31, 2025.

Aakashdeep | 10 November 2026

State Street Reports 4.9% Stake in Eastern Bankshares

State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing a beneficial ownership position in the common stock of Eastern Bankshares Inc as of September 30, 2026.

Aakashdeep | 10 November 2026

Cullinan Therapeutics Files Q3 2026 Quarterly Report

Cullinan Therapeutics, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 10, 2026, disclosing operational and financial information for the third quarter.

Aditi Sarkar | 10 November 2026
Support

Hi! How can we help you today?

Loading…